Giraudeau Mathieu, Sepp Tuul, Ujvari Beata, Renaud François, Tasiemski Aurélie, Roche Benjamin, Capp Jean-Pascal, Thomas Frédéric
CREEC, UMR IRD 224-CNRS 5290-Université de Montpellier, Montpellier, France.
Institute of Ecology and Earth Sciences, University of Tartu, Vanemuise 46, Tartu 51014, Estonia.
Evol Med Public Health. 2019 Jun 7;2019(1):139-146. doi: 10.1093/emph/eoz017. eCollection 2019.
Extensive diversity (genetic, cytogenetic, epigenetic and phenotypic) exists within and between tumours, but reasons behind these variations, as well as their consistent hierarchical pattern between organs, are poorly understood at the moment. We argue that these phenomena are, at least partially, explainable by the evolutionary ecology of organs' theory, in the same way that environmental adversity shapes mutation rates and level of polymorphism in organisms. Organs in organisms can be considered as specialized ecosystems that are, for ecological and evolutionary reasons, more or less efficient at suppressing tumours. When a malignancy does arise in an organ applying strong selection pressure on tumours, its constituent cells are expected to display a large range of possible surviving strategies, from hyper mutator phenotypes relying on bet-hedging to persist (high mutation rates and high diversity), to few poorly variable variants that become invisible to natural defences. In contrast, when tumour suppression is weaker, selective pressure favouring extreme surviving strategies is relaxed, and tumours are moderately variable as a result. We provide a comprehensive overview of this hypothesis. Lay summary: Different levels of mutations and intra-tumour heterogeneity have been observed between cancer types and organs. Anti-cancer defences are unequal between our organs. We propose that mostly aggressive neoplasms (i.e. higher mutational and ITH levels), succeed in emerging and developing in organs with strong defences.
肿瘤内部和之间存在广泛的多样性(遗传、细胞遗传、表观遗传和表型),但目前对这些变异背后的原因以及它们在不同器官间一致的层次模式了解甚少。我们认为,这些现象至少部分可以用器官进化生态学理论来解释,就像环境逆境塑造生物体的突变率和多态性水平一样。生物体中的器官可被视为特殊的生态系统,出于生态和进化原因,它们在抑制肿瘤方面或多或少具有效率。当一个器官中出现恶性肿瘤并对肿瘤施加强大的选择压力时,其组成细胞预计会展现出一系列可能的生存策略,从依赖风险对冲持续存在的高突变表型(高突变率和高多样性)到少数自然防御难以察觉的低可变变异体。相反,当肿瘤抑制较弱时,有利于极端生存策略的选择压力会放松,肿瘤的变异性因此处于中等水平。我们对这一假说进行了全面概述。通俗总结:在癌症类型和器官之间观察到了不同程度的突变和肿瘤内异质性。我们体内各器官的抗癌防御能力并不相同。我们提出,大多数侵袭性肿瘤(即更高的突变和肿瘤内异质性水平)在具有强大防御能力的器官中成功出现并发展。